Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NSC348884 is a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis, inhibits cell proliferation at an IC50 of 1.7-4.0 μM in distinct cancer cell lines.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 35.00 | |
5 mg | In stock | $ 56.00 | |
10 mg | In stock | $ 97.00 | |
25 mg | In stock | $ 190.00 | |
50 mg | In stock | $ 312.00 | |
100 mg | In stock | $ 450.00 | |
500 mg | In stock | $ 987.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 77.00 |
Description | NSC348884 is a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis, inhibits cell proliferation at an IC50 of 1.7-4.0 μM in distinct cancer cell lines. |
Targets&IC50 | Nucleophosmin:1.7-4.0 μM |
In vitro | NSC348884 disrupts a defined hydrophobic pocket required for oligomerization. NSC348884 disrupts nucleophosmin oligomer formation by native polyacrylamide gel electrophoresis assay. NSC348884 upregulates p53. NSC348884 induces apoptosis. |
In vivo | In vivo invasion and intravasation (that is, the number of CTCs) are significantly inhibited after injection of NSC348884(as an inhibitor of NPM1 oligomerization) into the tumor-bearing mice. No significant difference in overall cell death is observed by histology in the treated tumors with the 4-hour brief treatments, suggesting that the inhibition seen is specific to migration.[2]. |
Molecular Weight | 636.79 |
Formula | C38H40N10 |
CAS No. | 81624-55-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (78.52 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NSC348884 81624-55-7 Apoptosis p53 lymphoma cancer inhibit SKOV3 MOSEC/Luc cell LNCaP doxorubicin Inhibitor NSC-348884 ES2 small molecular NSC 348884 inhibitor